Evidence map›Paper›PMID 35866138›Full record

ReviewWiley interdisciplinary reviews. Computational molecular science

In silico toxicology: From structure-activity relationships towards deep learning and adverse outcome pathways.

Jennifer Hemmerich, Gerhard F Ecker

Abstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Computational molecular science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. HazChemNet: A Deep Learning Model for Hazardous Chemical Prediction.International journal of molecular sciences · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Molecular docking andToxicology reports · 2024
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jennifer HemmerichDepartment of Pharmaceutical Chemistry University of Vienna Vienna Austria.ORCID https://orcid.org/0000-0003-0372-8956
Gerhard F EckerDepartment of Pharmaceutical Chemistry University of Vienna Vienna Austria.ORCID https://orcid.org/0000-0003-4209-6883

Funding

Austrian Science Fund FWF W 1232
6 · The paper itself

Abstract

In silico toxicology is an emerging field. It gains increasing importance as research is aiming to decrease the use of animal experiments as suggested in the 3R principles by Russell and Burch. In silico toxicology is a means to identify hazards of compounds before synthesis, and thus in very early stages of drug development. For chemical industries, as well as regulatory agencies it can aid in gap-filling and guide risk minimization strategies. Techniques such as structural alerts, read-across, quantitative structure-activity relationship, machine learning, and deep learning allow to use in silico toxicology in many cases, some even when data is scarce. Especially the concept of adverse outcome pathways puts all techniques into a broader context and can elucidate predictions by mechanistic insights. This article is categorized under:Structure and Mechanism > Computational Biochemistry and BiophysicsData Science > Chemoinformatics.

Indexed as

adverse outcome pathwaycomputational toxicologyin silico toxicologymachine learningread across

Identifiers

PMID35866138
PMCPMC9286356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.